Current Patent Journal
Publication of patent applications and events is undertaken by the Intellectual Property Office once a week. New notices are posted on the site every Monday and will remain published for 20 working days. Notices are also archived as appropriate every Monday.
Date of Journal: 10/12/2018
| Date Published | Date of Application in Bailiwick | Patent Title | Field of Invention | Registered Proprietor | Overseas Registration, Jurisdiction, Number & Link to Web | Bailiwick Registered Agent | Supporting Documents |
|---|---|---|---|---|---|---|---|
| 03/12/18 | 28/11/18 | Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments | A61K 39/395; A61K 9/19; A61K 9/00; A61K 47/18; A61K 47/26; C07K 16/28; A61K 39/00 | Merck Sharp & Dohme Corp. | European Patent Office | David Evans (Collas Crill IP) | - |
| 03/12/18 | 28/11/18 | High purity lipopeptides, lipopeptide micelles and processes for preparing same | C07K 7/08; C07K 5/097; A61K 38/10 A61P 31/04 | Cubist Pharmaceuticals, LLC | European Patent Office | David Evans (Collas Crill IP | - |
| 03/12/18 | 29/11/18 | Novel FXR (NR1H4) modulating compounds | A61K; A61P; C07D | Gilead Sciences, Inc. | European Patent Office
| David Evans (Collas Crill IP | - |
| 10/12/18 | 04/12/18 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | C07D 471/04; C07D 487/04; A61K 31/496; A61K 31/506; A61K 31/472; A61K 31/4725; A61K 31/427; A61K 31/4402; A61P 31/18; A61K 45/06 | ViiV Healthcare UK (No. 4) Limited | European Patent Office | David Evans (Collas Crill IP | - |
| 10/12/18 | 04/12/18 | Antiviral therapy | A61K 31/5365; A61K 31/505; A61P 31/18 | ViiV Healthcare Company | European Patent Office
| David Evans (Collas Crill IP | - |
| 10/12/18 | 04/12/18 | Antiviral therapy | A61K 31/5365; A61K 31/52; A61P 31/18 | ViiV Healthcare Company | European Patent Office | David Evans (Collas Crill IP | - |
